Insider sale
KYMERA THERAPEUTICS, INC.
$3.46M
37.74K shares
What this filing means
ATLAS VENTURE OPPORTUNITY FUND I, L.P. plans to sell 37.74K shares of KYMERA THERAPEUTICS, INC. valued at approximately $3.46M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/11/2025ACC: 0001178937-25-000090
10% Owner
Since Aug 2020
37.74K
Shares to sell
$3.46M
Approx. market value
976.00
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Series C
CASH
3/11/2020
976.00Total acquired976.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/11/2020 | Series C CASH | 976.00 | — |
| Total | 976.00 | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
36.77K
Market value
$3.37M
12/10/2025
Planned — Approximate Date
NASDAQ GMPlanned
Units to sell
976.00
Market value
$85.7K
12/11/2025
Total
Units
37.74K
Value
$3.46M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/10/2025 | 36.77K | $3.37M | — | Completed |
| Planned — Approximate Date | ||||
12/11/2025 | 976.00 | $85.7K | NASDAQ GM | Planned |
| Total | 37.74K | $3.46M | ||